Company Filing History:
Years Active: 2013
Title: Innovations by James Luo in Inhalation Delivery Systems
Introduction
James Luo is an accomplished inventor based in Quincy, MA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of inhalation delivery systems. His innovative work focuses on improving the efficiency and safety of drug delivery methods.
Latest Patents
James Luo holds a patent for a "Stable epinephrine suspension formulation with high inhalation delivery efficiency." This patent describes a stable suspension aerosol formulation of epinephrine that is suitable for administration through inhalation. The formulation comprises a therapeutically effective amount of epinephrine, hydrofluorocarbon propellant, co-solvent, surfactant, and antioxidant. The unique aspect of this formulation is that it includes pre-micronized epinephrine suspended in an alcohol/surfactant solution with hydrofluoroalkane propellant. This innovative suspension formulation provides a highly efficient delivery of drug microparticles into the respirable region of patients' lungs. It offers several advantages, including lower dosage requirements, minimal alcohol content, reduced impurities during storage, improved efficacy and safety, and no ozone-depleting potential compared to formulations containing chlorofluorocarbon.
Career Highlights
James Luo is currently associated with Amphastar Pharmaceuticals, Inc., where he continues to work on advancing pharmaceutical technologies. His expertise in inhalation delivery systems has positioned him as a key player in the industry.
Collaborations
James has collaborated with notable colleagues, including Jianxin Gao and Rong Zhou, who have contributed to his research and development efforts.
Conclusion
James Luo's innovative work in the field of inhalation delivery systems exemplifies the importance of advancements in pharmaceutical formulations. His patent for a stable epinephrine suspension formulation highlights his commitment to improving drug delivery methods for better patient outcomes.